Parent Company Financials. (Tables)
|
6 Months Ended |
Jun. 30, 2021 |
| Condensed Financial Information Disclosure [Abstract] |
|
| Schedule of parent company financial statements |
| |
|
June
30, 2021 |
|
|
December 31, 2020 |
|
| ASSETS |
|
|
|
|
|
|
| Current Assets: |
|
|
|
|
|
|
| Cash and cash equivalents |
|
$ |
15,128 |
|
|
$ |
25,632 |
|
| Receivables from subsidiaries |
|
|
13,460 |
|
|
|
15,548 |
|
| Other current assets |
|
|
2,588 |
|
|
|
1,836 |
|
| Total current assets |
|
|
31,176 |
|
|
|
43,016 |
|
| |
|
|
|
|
|
|
|
|
| Property and equipment, net |
|
|
108 |
|
|
|
142 |
|
| Other Assets: |
|
|
|
|
|
|
|
|
| Investments in subsidiaries |
|
|
264,645 |
|
|
|
246,518 |
|
| Alto West, LLC receivable |
|
|
27,592 |
|
|
|
42,649 |
|
| Right of use operating lease assets, net |
|
|
2,844 |
|
|
|
2,985 |
|
| Other assets |
|
|
796 |
|
|
|
1,088 |
|
| Total other assets |
|
|
295,877 |
|
|
|
293,240 |
|
| Total Assets |
|
$ |
327,161 |
|
|
$ |
336,398 |
|
| Current Liabilities: |
|
|
|
|
|
|
|
|
| Accounts payable and accrued liabilities |
|
$ |
5,439 |
|
|
$ |
2,001 |
|
| Accrued Alto Op Co. purchase |
|
|
3,829 |
|
|
|
3,829 |
|
| Current portion of long-term debt |
|
|
6,696 |
|
|
|
25,533 |
|
| Other current liabilities |
|
|
329 |
|
|
|
473 |
|
| Total current liabilities |
|
|
16,293 |
|
|
|
31,836 |
|
| |
|
|
|
|
|
|
|
|
| Long-term debt, net of current portion |
|
|
— |
|
|
|
5,564 |
|
| Other liabilities |
|
|
2,849 |
|
|
|
2,763 |
|
| Total Liabilities |
|
|
19,142 |
|
|
|
40,163 |
|
| Stockholders’ Equity: |
|
|
|
|
|
|
|
|
| Preferred stock |
|
|
1 |
|
|
|
1 |
|
| Common and non-voting common stock |
|
|
73 |
|
|
|
72 |
|
| Additional paid-in capital |
|
|
1,035,980 |
|
|
|
1,036,638 |
|
| Accumulated other comprehensive loss |
|
|
(3,878 |
) |
|
|
(3,878 |
) |
| Accumulated deficit |
|
|
(724,157 |
) |
|
|
(736,598 |
) |
| Total Alto Ingredients, Inc. stockholders’ equity |
|
|
308,019 |
|
|
|
296,235 |
|
| Total Liabilities and Stockholders’ Equity |
|
$ |
327,161 |
|
|
$ |
336,398 |
|
|
| Schedule of statement of operations parent company |
| |
|
Three
Months Ended June 30, |
|
|
Six
Months Ended June 30, |
|
| |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Management fees from subsidiaries |
|
$ |
2,486 |
|
|
$ |
2,873 |
|
|
$ |
5,012 |
|
|
$ |
6,126 |
|
| Selling, general and administrative expenses |
|
|
4,393 |
|
|
|
4,308 |
|
|
|
9,044 |
|
|
|
9,685 |
|
| Income (loss) from operations |
|
|
(1,907 |
) |
|
|
(1,435 |
) |
|
|
(4,032 |
) |
|
|
(3,559 |
) |
| Fair value adjustments |
|
|
— |
|
|
|
(1,314 |
) |
|
|
— |
|
|
|
(641 |
) |
| Interest expense, net |
|
|
(704 |
) |
|
|
(1,721 |
) |
|
|
(1,731 |
) |
|
|
(3,297 |
) |
| Other income (expense) |
|
|
410 |
|
|
|
(140 |
) |
|
|
1,218 |
|
|
|
(162 |
) |
| Loss before benefit for income taxes |
|
|
(2,201 |
) |
|
|
(4,610 |
) |
|
|
(4,545 |
) |
|
|
(7,659 |
) |
| Benefit for income taxes |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Net loss |
|
|
(2,201 |
) |
|
|
(4,610 |
) |
|
|
(4,545 |
) |
|
|
(7,659 |
) |
| Equity in income (losses) of subsidiaries |
|
|
10,591 |
|
|
|
19,574 |
|
|
|
17,613 |
|
|
|
(2,477 |
) |
| Net income (loss) attributed to Alto Ingredients, Inc. |
|
$ |
8,390 |
|
|
$ |
14,964 |
|
|
$ |
13,068 |
|
|
$ |
(10,136 |
) |
|
| Schedule of statement of cash flows parent company |
| |
|
For
the Six Months Ended
June 30, |
|
| |
|
2021 |
|
|
2020 |
|
| Operating Activities: |
|
|
|
|
|
|
| Net income (loss) |
|
$ |
13,068 |
|
|
$ |
(10,136 |
) |
| Adjustments to reconcile net income (loss) to cash used in operating activities: |
|
|
|
|
|
|
|
|
| Equity in (income) losses of subsidiaries |
|
|
(17,613 |
) |
|
|
2,477 |
|
| Fair value adjustments |
|
|
— |
|
|
|
(641 |
) |
| Depreciation |
|
|
33 |
|
|
|
67 |
|
| Amortization of debt (premiums) discounts |
|
|
409 |
|
|
|
(115 |
) |
| Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
| Accounts receivable |
|
|
2,088 |
|
|
|
(1,207 |
) |
| Other assets |
|
|
(319 |
) |
|
|
714 |
|
| Accounts payable and accrued expenses |
|
|
(2,416 |
) |
|
|
— |
|
| Accounts payable with subsidiaries |
|
|
37 |
|
|
|
475 |
|
| Net cash used in operating activities |
|
|
(4,713 |
) |
|
|
(8,366 |
) |
| Investing Activities: |
|
|
|
|
|
|
|
|
| Additions to property and equipment |
|
|
— |
|
|
|
— |
|
| Net cash used in investing activities |
|
|
— |
|
|
|
— |
|
| Financing Activities: |
|
|
|
|
|
|
|
|
| Proceeds from issuances of common stock |
|
|
462 |
|
|
|
282 |
|
| Proceeds from plant receivables |
|
|
15,057 |
|
|
|
5,813 |
|
| Proceeds from long-term debt |
|
|
— |
|
|
|
5,973 |
|
| Payments on senior notes |
|
|
(24,810 |
) |
|
|
— |
|
| Dividend from subsidiary |
|
|
3,500 |
|
|
|
— |
|
| Net cash provided by (used in) financing activities |
|
|
(5,791 |
) |
|
|
12,068 |
|
| Net change in cash and cash equivalents |
|
|
(10,504 |
) |
|
|
3,702 |
|
| Cash and cash equivalents at beginning of period |
|
|
25,632 |
|
|
|
4,985 |
|
| Cash and cash equivalents at end of period |
|
$ |
15,128 |
|
|
$ |
8,687 |
|
|